维立志博-B拟实施H股全流通计划
LEADS BIOLABS-BLEADS BIOLABS-B(HK:09887) Zhi Tong Cai Jing·2025-12-15 12:54

Core Viewpoint - The company has submitted filing materials to the China Securities Regulatory Commission for the implementation of H-share full circulation, converting a total of 44.3916 million unlisted shares into H-shares, which represents approximately 22.32% of the company's total issued share capital of 199 million shares as of the announcement date [1] Group 1 - The company plans to convert 44.3916 million unlisted shares into H-shares [1] - The conversion will account for about 22.32% of the total issued share capital [1] - The filing was submitted to the China Securities Regulatory Commission on December 15, 2025 [1]